Evidence map›Paper›PMID 20397268›Full record

ArticleWorld journal of gastroenterology2010

Prognosis of cancer with branch duct type IPMN of the pancreas.

Nobuhito Ikeuchi, Takao Itoi, Atsushi Sofuni, Fumihide Itokawa, Takayoshi Tsuchiya, Toshio Kurihara, Kentaro Ishii, Shujiro Tsuji, Junko Umeda, Fuminori Moriyasu and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Early diagnosis of pancreatic cancer: Current trends and concerns.Annals of gastroenterological surgery · 2017
    Review
  5. Endoscopic approach to the diagnosis of pancreatic cystic tumor.World journal of gastrointestinal oncology · 2016
    Review
  6. Review
  7. Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2015
    Review
  8. Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013
    Review
  9. Article
  10. Article
  11. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2012
    Article
  12. [Intraductal papillary mucinous neoplasia: which findings support observation?].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2012
    Review
  13. Controversies in the management of pancreatic IPMN.Nature reviews. Gastroenterology & hepatology · 2011
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Nobuhito IkeuchiDepartment of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjyuku, Shinjyuku-ku, Tokyo 160-0023, Japan.
Takao Itoi
Atsushi Sofuni
Fumihide Itokawa
Takayoshi Tsuchiya
Toshio Kurihara
Kentaro Ishii
Shujiro Tsuji
Junko Umeda
Fuminori Moriyasu
Akihiko Tsuchida
Kazuhiko Kasuya
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo examine the coexistence of metachronous and synchronous cancer in branch duct intraductal papillary mucinous neoplasms of the pancreas (IPMN).

methodsWe reviewed the records of 145 patients with branch duct IPMN between January 1991 and April 2008 and assessed the relationship between IPMN and intra- or extra-pancreatic carcinoma and the outcome of IPMN.

resultsThe mean observation period was 55.9 +/- 45.3 mo. Among the 145 patients, the frequency of extra-pancreatic cancer was 29.0%. The frequency of gastric cancer, colon cancer, breast cancer, and pancreatic cancer were 25.5%, 15.7%, 13.7%, and 9.8%, respectively. Twenty (13.8%) of the patients died. The cause of death was extra-pancreatic carcinoma in 40%, pancreatic cancer in 25%, IPMN per se in 20%, and benign disease in 15% of the patients.

conclusionThe prognosis for IPMN depends not on the IPMN per se, but on the presence of intra- or extra-pancreatic cancer.

Indexed as

AdultAgedAged, 80 and overCarcinoma, Pancreatic DuctalFemaleFollow-Up StudiesHumansMaleMedical OncologyMiddle AgedPancreatic NeoplasmsPrognosisTreatment OutcomeExtra-pancreatic cancerIntraductal papillary mucinous neoplasms of the pancreasLong-term follow-upPancreatic cancerPrognosis

Identifiers

PMID20397268
PMCPMC2856831
OpenAlexW2152335231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.